CSI Market
Sign In | Register

Lakewood-Amedex Biotherapeutics (LABT) Annual Balance Sheets

Annual · GAAP · USD millions
Access LABT quarterly Balance Sheets →
This balance sheet overview for Lakewood-Amedex Biotherapeutics spans from to Dec 31 2025, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
Assets
Cash & cash equivalent0.24
Cash & Short-term Investments0.00
Total loans net0.07
Total Current Assets0.31
Equipment/Property/Plant Net0.01
Total Assets0.48
Liabilities
Accounts Payable0.38
Total Current Liabilities2.41
Total Long-term Debt0.00
Total Liabilities2.45
Stockholders' Equity
Common Stock Value0.00
Treasury Stock Value0.15
Additional Paid In Capital Common Stock51.53
Retained Earnings / Accumulated Deficit-53.35
Common Stockholder's Equity-1.96
Total Stockholder's Equity-1.96
Liabilities & Stockholder's Equity0.48
4 historic quarters locked

Sign in to unlock the full Lakewood-Amedex Biotherapeutics balance sheet history.

Sign In Create Free Account

About Lakewood Amedex Biotherapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-089380

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License